Diagnostic strategy in segmentation defect of the vertebrae: a retrospective study of 73 patients

Archive ouverte

Lefebvre, Mathilde | Dieux-Coeslier, Anne | Baujat, Geneviève | Schaefer, Elise | Judith, Saint-Onge | Bazin, Anne | Pinson, Lucile | Attié-Bitach, Tania | Baumann, Clarisse | Fradin, Mélanie | Pierquin, Geneviève | Julia, Sophie | Quélin, Chloé | Doray, Bérénice | Berg, Sylvie | Vincent-Delorme, Catherine | Lambert, Laetitia | Bachmann, Nadine | Lacombe, Didier | Isidor, Bertrand | Laurent, Nicole | Joelle, Roume | Blanchet, Patricia | Odent, Sylvie | Kervran, Dominique | Leporrier, Nathalie | Abel, Carine | Segers, Karine | Guiliano, Fabienne | Ginglinger-Fabre, Emmanuelle | Selicorni, Angelo | Goldenberg, Alice | El Chehadeh, Salima | Francannet, Christine | Demeer, Bénédicte | Duffourd, Yannis | Thauvin-Robinet, Christel | Verloes, Alain | Cormier-Daire, Valérie | Riviere, Jean Baptiste | Faivre, Laurence | Thevenon, Julien

Edité par CCSD ; BMJ Publishing Group -

International audience. Background Segmentation defects of the vertebrae (SDV) are non-specific features found in various syndromes. The molecular bases of SDV are not fully elucidated due to the wide range of phenotypes and classification issues. The genes involved are in the Notch signalling pathway, which is a key system in somitogenesis. Here we report on mutations identified in a diagnosis cohort of SDV. We focused on spondylocostal dysostosis (SCD) and the phenotype of these patients in order to establish a diagnostic strategy when confronted with SDV.Patients and methods We used DNA samples from a cohort of 73 patients and performed targeted sequencing of the five known SCD-causing genes (DLL3, MESP2, LFNG, HES7 and TBX6) in the first 48 patients and whole-exome sequencing (WES) in 28 relevant patients.Results Ten diagnoses, including four biallelic variants in TBX6, two biallelic variants in LFNG and DLL3, and one in MESP2 and HES7, were made with the gene panel, and two diagnoses, including biallelic variants in FLNB and one variant in MEOX1, were made by WES. The diagnostic yield of the gene panel was 10/73 (13.7%) in the global cohort but 8/10 (80%) in the subgroup meeting the SCD criteria; the diagnostic yield of WES was 2/28 (8%).Conclusion After negative array CGH, targeted sequencing of the five known SCD genes should only be performed in patients who meet the diagnostic criteria of SCD. The low proportion of candidate genes identified by WES in our cohort suggests the need to consider more complex genetic architectures in cases of SDV.

Consulter en ligne

Suggestions

Du même auteur

PFMG2025–integrating genomic medicine into the national healthcare system in France

Archive ouverte | Abadie, Caroline | CCSD

International audience. Integrating genomic medicine into healthcare systems is a health policy challenge that requires continuously transferring scientific advances into clinics and ensuring equal access for patien...

Treacher Collins syndrome: a clinical and molecular study based on a large series of patients.

Archive ouverte | Vincent, Marie | CCSD

International audience. Purpose - Treacher Collins/Franceschetti syndrome (TCS; OMIM 154500) is a disorder of craniofacial development belonging to the heterogeneous group of mandibulofacial dysostoses. TCS is class...

Further delineation of the MECP2 duplication syndrome phenotype in 59 French male patients, with a particular focus on morphological and neurological features

Archive ouverte | Miguet, Marguerite | CCSD

IF 5.751. International audience. The Xq28 duplication involving the MECP2 gene (MECP2 duplication) has been mainly described in male patients with severe developmental delay (DD) associated with spasticity, stereot...

Chargement des enrichissements...